Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families
Listen to this summary
The authors investigate the safety of dupilumab in pediatric patients with atopic dermatitis, specifically addressing concerns about the potential increased risk of cutaneous T-cell lymphoma (CTCL) associated with the treatment. They aim to provide evidence-based recommendations for monitoring and counseling families, particularly in light of recent data and the challenges posed by the diagnostic overlap between atopic dermatitis and CTCL.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Pediatric dermatology
View all →Jun 1, 2026 · Pediatric dermatology
Unilateral Forearm Ulceration in a Newborn: Thinking Outside the Box (Compartment)
May 31, 2026 · Pediatric dermatology
Ten-Year Epidemiology and Antimicrobial Susceptibility of Pediatric Staphylococcal Scalded Skin Syndrome: A Retrospective Study From a Tertiary Referral Center
More in Dermatology
View all →Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Sep 22, 2026 · Lancet (London, England)
Understanding peripheral arterial disease in the current era
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


